Do not change the dosage of this medicine or stop taking it without consulting your healthcare provider
Clinical evidence with unimolecular GLP-1R/GcgR dual-agonists Clinical research into the benefits and drawbacks of hybridized unimolecular GLP-1/Glucagon dual-agonists has escalated in recent time
SKU: 41
Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, Ali S, Kim M, Kabir MG, Seino Y, Suzuki J, Drucker DJ (2018) Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction
S.JangB.-S.et al (2016)
"International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 88"